Decoding the mechanism of andrographolide to combat hepatocellular carcinoma: a network pharmacology integrated molecular docking and dynamics approach

被引:6
|
作者
Dixit, Nandan [1 ]
Motwani, Harsha [1 ]
Patel, Saumya K. [1 ]
Rawal, Rakesh M. [2 ]
Solanki, Hiteshkumar A. [1 ]
机构
[1] Gujarat Univ, Dept Bot Bioinformat & Climate Change Impacts Mana, Ahmadabad, Gujarat, India
[2] Gujarat Univ, Sch Sci, Dept Life Sci, Ahmadabad, Gujarat, India
来源
关键词
hepatoCellular carcinoma; andrographolide; network pharmacology; molecular docking and molecular dynamic simulation; STEM-CELL DIFFERENTIATION; NATURAL-PRODUCTS; CANCER-CELLS; PANICULATA; GENES; TOOL; BIOINFORMATICS; IDENTIFICATION; INHIBITION; ANNOTATION;
D O I
10.1080/07391102.2023.2256866
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HepatoCellular Carcinoma, being one of the most mortally convoluted malignancy with mounting number of occurrences across the world and being classified as the third most prevalent cause of cancer-associated mortalities and sixth most prevalent neoplasia. The active phytoconstituent andrographolide, derived from Andrographis paniculata is conveyed to reconcile a number of human ailments including various oncologies. However, the molecular mechanism underlying the anti-oncogenic effects of Andrographolide on HCC remains skeptical and unclear, emerging as a budding challenge for researchers and oncologists. The present study intends to analyze the underlying pharmacological mechanism of Andrographolide over HCC, established via assimilated approach of network pharmacology. Herein, the Network pharmacology stratagem was instigated to investigate potential HCC targets. The Andrographolide targets along with HCC targets were extracted from multiple databases. A total of 162 potential overlapping targets among HCC and Andrographolide were obtained and further subjected to gene ontology and Pathway enrichment analysis by employing OmicsBox and DAVID database, respectively. Subsequently, Protein-protein interaction network construction by Cytoscape software identified the top 10 hub nodes which were validated by survival and expression analysis. Further, the results derived from molecular docking and dynamic simulations by CB-Dock2 server and Desmond module (Schrodinger software) indicate ALB, CCND1, HIF1A, TNF, and VEGFA as potential Andrographolide related targets with high binding affinity and promising complex stability. Our findings not only reveal the antioncogenic role of andrographolide but also provide novel insights illuminating the identified targets as scientific foundation for anti-oncogenic clinical application of andrographolide in HCC therapeutics.Communicated by Ramaswamy H. Sarma
引用
收藏
页码:10237 / 10255
页数:19
相关论文
共 50 条
  • [41] Network pharmacology and molecular docking integrated strategy to investigate the pharmacological mechanism of palmatine in Alzheimer's disease
    Pei, Hongyan
    Zeng, Jianning
    Chen, Weijia
    He, Zhongmei
    Du, Rui
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2022, 36 (11)
  • [42] Integrated network pharmacology, molecular docking and experimental validation to investigate the mechanism of tannic acid in nasopharyngeal cancer
    Wang, Meiwei
    He, Longmei
    Yan, Pan
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [43] Integrated network pharmacology and molecular docking to investigate the potential mechanism of Tufuling on Alzheimer's ' s disease
    Zhang, Ziyou
    Cheng, Jiamao
    Zhou, Xinpei
    Wu, Haoyi
    Zhang, Bensi
    HELIYON, 2024, 10 (16)
  • [44] Molecular docking and molecular dynamics simulation decoding molecular mechanism of EDCs binding to hERRγ
    Sun, Ying
    Chen, Lin
    Zhao, Bing
    Wang, Ruige
    JOURNAL OF MOLECULAR MODELING, 2024, 30 (05)
  • [45] Network Pharmacology and Molecular Docking Integrated with Molecular Dynamics Simulations Investigate the Pharmacological Mechanism ofYinchenhao Decoction in the Treatment of Non-alcoholic Fatty LiverDisease
    Yang, Rong
    Jiang, Dansheng
    Xu, Hongling
    Yang, Huili
    Feng, Lian
    Wu, Qibiao
    Xing, Yufeng
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2024,
  • [46] Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking
    Jie Su
    Mengmeng Huo
    Fengnan Xu
    Liqiong Ding
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 1551 - 1559
  • [47] Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking
    Su, Jie
    Huo, Mengmeng
    Xu, Fengnan
    Ding, Liqiong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (03) : 1551 - 1559
  • [48] Potential Target Metabolites From Gut Microbiota Against Hepatocellular Carcinoma: A Network Pharmacology and Molecular Docking Study
    Aslam, Sehar
    Qasim, Muhammad
    Noor, Fatima
    Shahid, Muhammad
    Ashfaq, Usman Ali
    Munir, Samman
    Al-Harthi, Helal F.
    Mashraqi, Mutaib M.
    Waqas, Umair
    Khurshid, Mohsin
    INTERNATIONAL JOURNAL OF MICROBIOLOGY, 2024, 2024
  • [49] Exploring molecular mechanism of Panlongqi Tablet (PLQT) against RA: Integrated network pharmacology, molecular docking and experiment validation
    Song, Huixin
    Yu, Jinjin
    Yang, Yajie
    Zhou, Lili
    Liu, Xinyao
    Yu, Jiabao
    Huang, Qiuxia
    Wang, Siqi
    Zhang, Xinya
    Liu, Yang
    Zhang, Dezhu
    Meng, Jianguo
    Han, Tengfei
    Li, Weifeng
    Niu, Xiaofeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 144
  • [50] Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study Based on Network Pharmacology, Molecular Docking and Bioinformatics
    Wan, Yuxiang
    Jiang, Honglin
    Liu, Zeyu
    Bai, Chen
    Lian, Yanyan
    Zhang, Chunguang
    Zhang, Qiaoli
    Huang, Jinchang
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (24) : 1894 - 1911